Pharmacokinetics & PK/PD Modeling Vendors
PK analysis, exposure-response, PK/PD modeling, simulation, and interpretation for preclinical or candidate-enabling studies.
Related workflows
CRO / Research Services Provider · +5 more types
Inotiv is a CRO and research models provider offering toxicology, in vivo pharmacology, research and transgenic models, bioanalysis and DMPK.
Products: Teklad, Target Sufficiency +1 more
Evidence-backed capability match
“Whatever the source of your data, we will perform PK-TK analyses to evaluate dose, DDI potential, bioequivalence/bioavailability, and/or clinical PK projections.”Source: inotiv.com
Also offers: Toxicology Studies, In Vivo Pharmacology & Efficacy Models, +3 more
CRO / Research Services Provider · +3 more types
Altasciences is an early phase CRO and CDMO providing toxicology, IND-enabling studies, clinical pharmacology, bioanalysis, and drug manufacturing.
Products: Acceleration Platform
Evidence-backed capability match
“We also develop thorough PK models and conduct simulations that help determine half-life, clearance pathways, bioavailability, and volume of distribution.”Source: altasciences.com
Also offers: Toxicology Studies, First-in-Human (Phase I) Clinical Pharmacology Support, +2 more
CRO / Research Services Provider · +4 more types
Crown Bioscience is a translational oncology CRO offering in vivo efficacy studies, PDX and cancer models, biomarker discovery, and clinical biomarker testing.
Products: OrganoidXplore, HuGEMM +3 more
Evidence-backed capability match
“By leveraging our current core platforms/expertise (PDX, PDO, in vitro, biomarker), we offer integrated solutions for pharmacokinetics and pharmacodynamic to support preclinical…”Source: crownbio.com
Also offers: In Vivo Pharmacology & Efficacy Models, Oncology Models & PDX Studies, +2 more
CRO / Research Services Provider · +5 more types
Frontage Laboratories is a CRO and CDMO providing bioanalysis, DMPK and ADME studies, toxicology, Phase I support, and drug manufacturing.
Evidence-backed capability match
“Frontage scientists conduct toxicokinetic analysis for the bioanalytical data generated from plasma sample analysis from IND-enabling GLP toxicology studies and prepare a…”Source: frontagelab.com
Also offers: Bioanalysis & Biomarker Assay Services, Integrated CDMO/CMO Services, +3 more
Software / Technology Platform · +4 more types
Simulations Plus is a drug-development software and consulting provider offering PBPK modeling, pharmacometrics and QSP, and AI-driven drug design.
Products: GastroPlus, MonolixSuite +9 more
Evidence-backed capability match
“Preclinical pharmacokinetics (PK) and Toxicokinetics (TK)”Source: simulations-plus.com
Also offers: Model-Informed Drug Development (MIDD), PBPK Modeling, +3 more
Compare listed vendors
| Vendor | Delivery model | Also offers | In their words |
|---|---|---|---|
| Altasciences | CRO / Research Services Provider | Drug Metabolism, Pharmacokinetics & ADME Studies, In Vitro ADME, CYP & Metabolism Assays | “We also develop thorough PK models and conduct simulations that help determine half-life, clearance pathways, bioavailability, and volume of distribution.”altasciences.com · reviewed Oct 21, 2026 |
| Crown Bioscience | CRO / Research Services Provider | Drug Metabolism, Pharmacokinetics & ADME Studies, In Vitro ADME, CYP & Metabolism Assays | “By leveraging our current core platforms/expertise (PDX, PDO, in vitro, biomarker), we offer integrated solutions for pharmacokinetics and pharmacodynamic to…”crownbio.com · reviewed Oct 21, 2026 |
| Frontage Laboratories | CRO / Research Services Provider | Drug Metabolism, Pharmacokinetics & ADME Studies, In Vitro ADME, CYP & Metabolism Assays, Drug-Drug Interaction & Transporter Studies | “Frontage scientists conduct toxicokinetic analysis for the bioanalytical data generated from plasma sample analysis from IND-enabling GLP toxicology studies…”frontagelab.com · reviewed Oct 21, 2026 |
| Inotiv | CRO / Research Services Provider | Drug Metabolism, Pharmacokinetics & ADME Studies, In Vitro ADME, CYP & Metabolism Assays, Drug-Drug Interaction & Transporter Studies | “Whatever the source of your data, we will perform PK-TK analyses to evaluate dose, DDI potential, bioequivalence/bioavailability, and/or clinical PK…”inotiv.com · reviewed Oct 21, 2026 |
| Simulations Plus | Software / Technology Platform | — | “Preclinical pharmacokinetics (PK) and Toxicokinetics (TK)”simulations-plus.com · reviewed Oct 26, 2026 |